✦ LIBER ✦

Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial

✍ Scribed by MacKenzie Feder, Jessica; Bourdeau, Isabelle; Vallette, Sophie; Beauregard, Hugues; Ste-Marie, Louis-Georges; Lacroix, André

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Up-to 5-year efficacy of pasireotide in

✍ Trementino, Laura; Cardinaletti, Marina; Concettoni, Carolina; Marcelli, Giorgia 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 299 KB

Long-term safety and efficacy of linagli

✍ R. Gomis; D. R. Owens; M.-R. Taskinen; S. Del Prato; S. Patel; A. Pivovarova; A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Sixteen years follow-up results of a ran

✍ Leone, JosÃ© Pablo; Leone, Julieta; Vallejo, Carlos Teodoro; PÃ©rez, Juan Eduard 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 359 KB